Smolenski, J.W
JACC 84(1):2740 Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Taken together, our findings suggest that the reduced body weight and adiposity observed in GPR146-deficient mice are likely due to an increase in energy expenditure
Because discontinuing Tirzepatide often results in weight regain, we typically recommend ongoing therapy unless you experience side effects, insufficient results, or other health concerns
But we must get to the 90s to use these new peptides for pharmacological purposes in the treatment of type 2 diabetes
Research findings: KPV has been studied primarily in models of intestinal inflammation (colitis), skin inflammation, and joint inflammation